Loading...
dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1208689007

Production
add
1208689007
The component that hold information about this concept.
Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
Alogliptin and pioglitazone only product in oral dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)

SCTID: 1208689007, Defined, Active


1208689007|Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)|
  • en Alogliptin and pioglitazone only product in oral dose form
  • en Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)

1208689007 |Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)|

=== 385268001 |Oral dosage form (qualifier value)| +
    1208687009 |Product containing only alogliptin and pioglitazone (medicinal product)| +
    1208688004 |Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)| :
        { 127489000 |Has active ingredient (attribute)| = 395828009 |Pioglitazone (substance)| }
        { 127489000 |Has active ingredient (attribute)| = 702799001 |Alogliptin (substance)| }
Active

4970513016 - Alogliptin and pioglitazone only product in oral dose form (en) View

4970513016
en
Synonym (core metadata concept)
Alogliptin and pioglitazone only product in oral dose form
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

4970514010 - Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form) (en) View

4970514010
en
Fully specified name (core metadata concept)
Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

1208687009 View

1208687009
Product containing only alogliptin and pioglitazone (medicinal product)
Alogliptin and pioglitazone only product
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

1208688004 View

1208688004
Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)
Alogliptin- and pioglitazone-containing product in oral dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

385268001 View

385268001
Oral dosage form (qualifier value)
Oral dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

1208690003 View

1208690003
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Alogliptin (as alogliptin benzoate) 25 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

1208691004 View

1208691004
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
Alogliptin (as alogliptin benzoate) 25 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

1208692006 View

1208692006
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)
Alogliptin (as alogliptin benzoate) 25 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

1208693001 View

1208693001
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

1208694007 View

1208694007
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

1208695008 View

1208695008
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True
esc